Skip to main content
. 2023 Sep 7;9(9):e19951. doi: 10.1016/j.heliyon.2023.e19951

Table 2.

Inhibitors of IL-1β signaling pathways in IDD.

Substances Sources Classification Signaling pathway Effects References
Anakinra Synthetic IL-1Ra IL-1β to IL-1 receptors Inflammation⬇ECM degradation⬇ [49]
Ganoderic Acid A Natural Triterpenoid IL-1β/NF-κB pathway Inflammation⬇ECM degradation⬇ 42
Cardamonin Natural Chalcone IL-1β/NF-κB pathway Inflammation⬇ECM degradation⬇ 43
Suramin Synthetic Naphthoquinone IL-1β/NF-κB pathway Apoptosis⬇Inflammation⬇ECM degradation⬇ 45
Andrographolide Natural Diterpenoid TLR4/MyD88/NF-κB pathway Apoptosis⬇ECM degradation⬇ [50]
Naringin Natural Flavonoid NF-κB pathway and expression of p53 Inflammation⬇ECM degradation⬇ [51]
Luteoloside Natural Flavonoid NF-κB pathway Apoptosis⬇Inflammation⬇ECM degradation⬇ [52]
Genistein Natural Flavonoid p38 MAPK pathway Inflammation⬇ECM degradation⬇ [53]
Simvastatin Synthetic Statins NF-κB and MAPK pathway Apoptosis⬇ECM degradation⬇ 64
Wogonin Natural Monoflavonoid IL-1β/MAPK pathway Inflammation⬇ECM degradation⬇ 27
U0126 Synthetic Aromatic ketones IL-1β/MAPK/ERK pathway Inflammation⬇ECM degradation⬇ 58
Melatonin Synthetic Indole derivatives IL-1β/NF-κB/NLRP3 pathway Inflammation⬇ 29
PRP-derived exosomes Synthetic / NLRP3 ubiquitination and NLRP3 autophagy Apoptosis⬇Inflammation⬇ [54]
Morin Natural Flavonol TXNIP/NLRP3/Caspase-1 pathway Pyroptosis⬇ 90